MATTHEW TOTTER: Open Payments
NPI 1396224390 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,432 in 69 payments from 13 companies in 2025. Trend: 2023 $880 · 2024 $1,172 · 2025 $1,432
Food & beverage: $1,416Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $455 |
| ABBVIE INC. | 26 | $325 |
| Lilly USA, LLC | 12 | $196 |
| Novo Nordisk Inc | 6 | $193 |
| Exact Sciences Corporation | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Amgen Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: VRAYLAR, Ozempic, FARXIGA, BREZTRI, AIRSUPRA, ZEPBOUND, QULIPTA, MOUNJARO.
Industry payments across NM — which companies pay providers there.
